VNRX - VOLITIONRX LTD
2.78
2.644 95.101%
Share volume: 377,519
Last Updated: 04-28-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.14
0.06
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Cash flow financing | -209.398 K | 5.603 M | 3.667 M | 5.670 M | 1.600 M | |
| Other financing cash flows | 0.000 | -44.073 K | -24.411 K | -22.631 K | -80.381 K | |
| Cash flow | -8.342 M | 79.141 K | -632.746 K | -669.448 K | 0.000 | |
| Net income | -8.367 M | -5.869 M | -5.477 M | -6.314 M | -5.410 M | |
| Depreciation | 322.073 K | 285.038 K | 251.941 K | 252.688 K | 248.253 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 133.500 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -78.809 K | -136.737 K | -1.808 K | -76.783 K | 0.000 | |
| Net Borrowings | -8.386 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -78.809 K | 136.737 K | 1.808 K | 76.783 K | 0.000 | |
| Cash Change | 11.772 M | -584.782 K | -664.087 K | -344.346 K | -2.057 M |